FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF U.A. enters BRAVEHEART BIO, INC. with 1.10M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 8/6/2026ACC: 0001193125-26-336143
→
10% Owner
Since Aug 2026
1.10M
Baseline shares
53% direct
588.13K
Direct ownership
1 position
17.12M
Derivative underlying
2 instruments
2
Security positions
514.61K indirect
Non-Derivative Holdings2
Common Stock
DirectShares owned588.13K
Common Stock
IndirectShares owned514.61K
Total
588.13K direct·514.61K indirect1.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 588.13K | Direct |
| Common Stock | 514.61K | Indirect |
| Total | 1.10M | 588.13K direct·514.61K indirect |
Derivative Holdings2
Series A Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
9.13M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
7.99M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
17.12M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series A Preferred Stock Direct | Common Stock | — | — | 9.13M | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 7.99M | N/A | |
| Total | 17.12M | 0.00 | ||||